Literature DB >> 19336423

Body mass index and Barrett's oesophagus in women.

B C Jacobson1, A T Chan, E L Giovannucci, C S Fuchs.   

Abstract

OBJECTIVE: Excess body mass is associated with symptoms of gastro-oesophageal reflux disease, and cross-sectional studies suggest an association between body mass index (BMI) and Barrett's oesophagus. The present study sought prospectively to examine the influence of BMI and other anthropomorphic measures on the risk for Barrett's oesophagus among women.
METHODS: This was a prospective study of 15 861 women who participated in the Nurses' Health Study, without a history of cancer, who underwent upper gastrointestinal endoscopy for any reason between 1986 and 2004. The main outcome measures were 261 cases of pathologically confirmed specialised intestinal metaplasia within the oesophagus (Barrett's oesophagus). Self-reported data on weight were collected from biennial questionnaires. Self-reported height was collected in 1976, and self-reported waist and hip circumferences were collected in 1986.
RESULTS: Compared with women with a BMI of 20-24.9 kg/m(2), women with a BMI of 25-29.9 had a multivariate OR for Barrett's oesophagus of 0.92 (95% CI 0.66 to 1.27), women with a BMI > or =30 had a multivariate OR of 1.52 (95% CI 1.02 to 2.28) and women with a BMI <20 had a multivariate OR of 0.92 (95% CI 0.65 to 1.31). Results were similar when controlling for symptoms of gastro-oesophageal reflux, and among the entire Nurses' Health Study cohort (n = 93 609) regardless of a history of endoscopy. In contrast, waist-to-hip ratio, waist circumference and height did not appear to be associated with Barrett's oesophagus.
CONCLUSIONS: Obese, but not overweight, women appear to be at increased risk for Barrett's oesophagus.

Entities:  

Mesh:

Year:  2009        PMID: 19336423      PMCID: PMC2763036          DOI: 10.1136/gut.2008.174508

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  73 in total

Review 1.  A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus.

Authors:  Michael B Cook; Darren C Greenwood; Laura J Hardie; Christopher P Wild; David Forman
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

3.  A pilot study of the association of low plasma adiponectin and Barrett's esophagus.

Authors:  Joel H Rubenstein; Anne Dahlkemper; John Y Kao; Min Zhang; Hal Morgenstern; Laurence McMahon; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

4.  The association of gastric leptin with oesophageal inflammation and metaplasia.

Authors:  F Francois; J Roper; A J Goodman; Z Pei; M Ghumman; M Mourad; A Z Olivares de Perez; G I Perez-Perez; C-H Tseng; M J Blaser
Journal:  Gut       Date:  2007-08-30       Impact factor: 23.059

5.  Barrett's esophagus and obesity: the missing part of the puzzle.

Authors:  Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2008-02       Impact factor: 10.864

6.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

7.  Leptin and the risk of Barrett's oesophagus.

Authors:  B J Kendall; G A Macdonald; N K Hayward; J B Prins; I Brown; N Walker; N Pandeya; A C Green; P M Webb; D C Whiteman
Journal:  Gut       Date:  2008-01-04       Impact factor: 23.059

8.  Postmenopausal hormone use and symptoms of gastroesophageal reflux.

Authors:  Brian C Jacobson; Beverly Moy; Graham A Colditz; Charles S Fuchs
Journal:  Arch Intern Med       Date:  2008-09-08

9.  Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses.

Authors:  Douglas A Corley; Ai Kubo; Jolanda DeBoer; Gregory J Rumore
Journal:  Gastrointest Endosc       Date:  2009-01-18       Impact factor: 9.427

10.  Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

View more
  19 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

3.  Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.

Authors:  Ian L P Beales; Leanne Dearman; Inna Vardi; Yoon Loke
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

Review 4.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

5.  Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.

Authors:  Prashanthi N Thota; Shamiq Zackria; Madhusudhan R Sanaka; Deepa Patil; John Goldblum; Rocio Lopez; Amitabh Chak
Journal:  J Clin Gastroenterol       Date:  2017 May/Jun       Impact factor: 3.062

6.  Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).

Authors:  Felipe Mazzoleni; Luiz Edmundo Mazzoleni; Carlos Fernando de Magalhães Francesconi; Guilherme Becker Sander; Pâmela Schitz Von Reisswitz; Tobias Cancian Milbradt; Rafael da Veiga Chaves Picon; Diego Mendonça Uchoa; Laura Renata De Bona; Huander Felipe Andreolla; Helenice Pankowski Breyer; Ronaldo Spinato Torresini; Eduardo André Ott; André Castagna Wortmann; Alexandro de Lucena Theil; Jonathas Stifft; Raquel Petrucci Zenker; Candice Franke Krumel; Matheus Truccolo Michalczuk; Alexandre De Araujo; Ane Paula Canevese; Nadja Volpato; Cristiano André da Silva; Pedro Guilherme Schaefer; Natacha Fleck Titton; Larisse Longo; Maria Isabel Edelweiss; Daniel Simon; Nicholas Joseph Talley
Journal:  Int J Obes (Lond)       Date:  2019-06-13       Impact factor: 5.095

7.  Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men.

Authors:  Jennifer R Kramer; Lori A Fischbach; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Bhupinderjit Anand; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-04       Impact factor: 11.382

8.  Total body fat and the risk of Barrett's oesophagus - a bioelectrical impedance study.

Authors:  Bradley J Kendall; Graeme A Macdonald; Johannes B Prins; Suzanne O'Brien; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2014-04-13       Impact factor: 2.984

9.  Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus.

Authors:  Joel H Rubenstein; Hal Morgenstern; William D Chey; Joseph Murray; James M Scheiman; Philip Schoenfeld; Henry D Appelman; Laurence McMahon; Val Metko; Joan Kellenberg; Tal Kalish; Jason Baker; John M Inadomi
Journal:  Gut       Date:  2013-03-05       Impact factor: 23.059

10.  Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

Authors:  Catherine Duggan; Lynn Onstad; Sheetal Hardikar; Patricia L Blount; Brian J Reid; Thomas L Vaughan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-01       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.